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Adverse outcomes after total and unicompartmental 
knee replacement in 101 330 matched patients: a study of 
data from the National Joint Registry for England and Wales
Alexander D Liddle, Andrew Judge, Hemant Pandit, David W Murray
Summary
Background Total knee replacement (TKR) or unicompartmental knee replacement (UKR) are options for end-stage 
osteoarthritis. However, comparisons between the two procedures are confounded by diﬀ erences in baseline 
characteristics of patients undergoing either procedure and by insuﬃ  cient reporting of endpoints other than revision. 
We aimed to compare adverse outcomes for each procedure in matched patients.
Methods With propensity score techniques, we compared matched patients undergoing TKR and UKR in the National 
Joint Registry for England and Wales. The National Joint Registry started collecting data in April 1, 2003, and is 
continuing. The last operation date in the extract of data used in our study was Aug 28, 2012. We linked data for 
multiple potential confounders from the National Health Service Hospital Episode Statistics database. We used 
regression models to compare outcomes including rates of revision, revision/reoperation, complications, readmission, 
mortality, and length of stay.
Findings 25 334 UKRs were matched to 75 996 TKRs on the basis of propensity score. UKRs had worse implant 
survival both for revision (subhazard ratio [SHR] 2·12, 95% CI 1·99–2·26) and for revision/reoperation (1·38, 
1·31–1·44) than TKRs at 8 years. Mortality was signiﬁ cantly higher for TKR at all timepoints than for UKR (30 day: 
hazard ratio 0·23, 95% CI 0·11–0·50; 8 year: 0·85, 0·79–0·92). Length of stay, complications (including 
thromboembolism, myocardial infarction, and stroke), and rate of readmission were all higher for TKR than for UKR.
Interpretation In decisions about which procedure to oﬀ er, the higher revision/reoperation rate of UKR than of TKR 
should be balanced against a lower occurrence of complications, readmission, and mortality, together with known 
beneﬁ ts for UKR in terms of postoperative function. If 100 patients receiving TKR received UKR instead, the result 
would be around one fewer death and three more reoperations in the ﬁ rst 4 years after surgery.
Funding Royal College of Surgeons of England and Arthritis Research UK.
Copyright © Liddle et al. Open Access article distributed under the terms of CC BY.
Introduction
Total knee replacement (TKR), usually undertaken for 
end-stage osteoarthritis, is one of the commonest 
surgical procedures, with more than 76 000 TKRs done 
every year in the UK.1 International trends suggest that 
this number will rise substantially, largely because of the 
ageing population and an increased prevalence of risk 
factors, including obesity.2
TKR is a highly successful and cost-eﬀ ective 
procedure. In terms of implant survival, more than 
95% are in situ 10 years after surgery.1,3,4 However, 
implant survival is an imperfect measure. With this 
measure, patients who have died, those who undergo 
reoperations that are not regarded as revisions (such as 
debridement for infection or manipulation under 
anaesthetic for stiﬀ ness), and those who have poorly 
functioning, but unrevised, knee replacements, are all 
classed as successes.5
The proportion of TKRs that is judged successful 
changes with the use of diﬀ erent outcome measures. 
90-day mortality after TKR is 0·4%,6 by 4 years, 3·8% of 
patients undergo a non-revision reoperation;7 8·5% of 
patients have worse patient-reported outcome measures 
6 months after knee replacement than they had 
beforehand;8 and up to 20% are dissatisﬁ ed after TKR.9
A large proportion of patients who are eligible for TKR 
are also eligible for unicompartmental knee replacement 
(UKR) in which only the parts of the knee aﬀ ected by 
osteoarthritis are replaced.10,11 Better patient reported 
outcomes can be obtained with UKR than with TKR, and 
mortality and major complications are lower after UKR 
than after TKR.4,12 However, unadjusted data from national 
registries show a signiﬁ cantly higher revision rate for 
UKR than for TKR.1,3,4 Because revision rate has 
traditionally been regarded as the most important factor 
to determine implant choice, only 8% of knee 
replacements done each year in the UK are UKRs, and 
most knee surgeons do not do them.
As such, the use of UKR in the treatment of end-stage 
osteoarthritis is controversial. Fair comparison of TKR 
and UKR is hampered by diﬀ erences in the baseline 
characteristics of patients being oﬀ ered each procedure 
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Crude p value Matched*
TKR UKR TKR UKR
Number of patients 315 767 25 982 75 996 25 334
Age at surgery (years) 70·4 (9·1) 64·3 (9·7) <0·0001 64·7 (9·3) 64·7 (9·4)
Unit type
Public hospital 269 857 (86%) 22 085 (85%) 0·044 64 179 (85%) 21 544 (85%)
Independent hospital 33 542 (11%) 2872 (11%) 0·030 9141 (12%) 2801 (11%)
Independent sector treatment centre 12 368 (4%) 1025 (4%) 0·822 2676 (4%) 989 (4%)
Thromboprophylaxis
Drugs
Unfractionated or low molecular weight heparin 209 221 (66%) 15 816 (61%) <0·0001 48 546 (64%) 15 438 (61%)
Aspirin 34 668 (11%) 3924 (15%) <0·0001 9519 (13%) 3858 (15%)
Warfarin 3447 (1%) 211 (1%) <0·0001 727 (1%) 208 (1%)
Direct thrombin inhibitor 12 487 (4%) 1101 (4%) 0·025 2654 (4%) 1050 (4%)
Other 23 410 (7%) 1927 (7%) 0·986 5205 (7%) 1830 (7%)
None/unspeciﬁ ed 32 514 (10%) 3003 (12%) <0·0001 9345 (12%) 2950 (12%)
Mechanical
Thromboembolic deterrent stockings 203 878 (65%) 16 772 (65%) 0·965 49 246 (65%) 16 323 (64%)
Foot pumps/intermittent calf compression 67 884  (22%) 5820 (22%) 0·001 16 686 (22%) 5653 (22%)
Other 4129 (1%) 272 (1%) <0·0001 1012 (1%) 266 (1%)
None/unspeciﬁ ed 39 876 (13%) 3118 (12%) 0·003 9052 (12%) 3092 (12%)
Indices of multiple deprivation (quintiles)13 
1 48 598 (15%) 2951 (11%) <0·0001 8744 (12%) 2915 (12%)
2 59 609 (19%) 4361 (17%) <0·0001 12 247 (16%) 4291 (17%)
3 70 398 (22%) 5791 (22%) 0·983 16 723 (22%) 5666 (22%)
4 71 870 (23%) 6179 (24%) <0·0001 19 070 (25%) 5986 (24%)
5 65 292 (21%) 6700 (26%) <0·0001 19 212 (25%) 6476 (26%)
Hypertension 140 581 (45%) 8926 (34%) <0·0001 26 542 (35%) 8851 (35%)
Sex (male) 135 515 (43%) 13 547 (52%) <0·0001 39 573 (52%) 13 106 (52%)
Fixation
Cemented 285 749 (91%) 23 407 (90%) 0·033 68 776 (91%) 22 822 (90%)
Uncemented 26 135 (8%) 1 944 (8%) <0·0001 5684 (8%) 1912 (8%)
Hybrid 3883 (1%) 631 (2%) <0·0001 1536 (2%) 600 (2%)
Ethnic origin
Undeﬁ ned 38 832 (12%) 3654 (14%) <0·0001 9983 (13%) 3593 (14%)
White 263 333 (83%) 21 506 (83%) 0·010 63 547 (84%) 20 934 (83%)
Mixed race 615 (<1%) 54 (<1%) 0·647 114 (<12%) 51 (<1%)
Asian 8587 (3%) 515 (2%) <0·0001 1643 (2%) 511 (2%)
Black 2992 (1%) 120 (1%) <0·0001 471 (1%) 116 (1%)
Other 1408 (1%) 133 (1%) 0·127 238 (<1%) 129 (1%)
Cases done by consultant 231 151 (73%) 22 255 (86%) <0·0001 64 998 (86%) 21 628 (85%)
Cases per consultant per year 73·9 (52·5) 85·7 (56·6) <0·0001 84·7 (58·8) 84·8 (55·5)
Comorbidities (Charlson index)14 
None 240 663 (76%) 20 865 (80%) <0·0001 60 935 (80%) 20 291 (80%)
Mild 60 152 (19%) 4298 (17%) <0·0001 12 560 (17%) 4233 (17%)
Moderate 11 389 (4%) 642 (3%) <0·0001 1988 (3%) 635 (3%)
Severe 3563 (1%) 177 (1%) <0·0001 513 (1%) 175 (1%)
American Society of Anesthesiologists score15
1 36 461 (12%) 5885 (23%) <0·0001 16 050 (21%) 5463 (22%)
2 228 079 (72%) 17 725 (68%) <0·0001 53 268 (70%) 17 507 (69%)
3+ 51 227 (16%) 2372 (16%) <0·0001 6678 (9%) 2364 (9%)
Data are n (%) or mean (SD). TKR=total knee replacement. UKR=unicompartmental knee replacement. *No signiﬁ cant diﬀ erences after matching.
Table 1: Baseline and matched demographics
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(known as confounding by indication); for instance, UKR 
is often oﬀ ered to younger patients who, because of their 
higher activity levels, tend to have better functional 
outcomes, but increased failure rates.1,3,4
The aim of this study was to comprehensively compare 
the rates of adverse outcomes after TKR and UKR, with 
large datasets from the National Joint Registry for 
England and Wales (NJR), Hospital Episode Statistics 
(HES), and the Oﬃ  ce for National Statistics (ONS). We 
have studied multiple outcomes, including complications, 
readmission, reoperation, and death.
Methods
Data source
We analysed NJR records linked to data from the HES 
database. The NJR began collecting data in 2003 and 
contains details of more than 1 million joint replacements, 
making it the largest joint registry in the world.1 For this 
study, we extracted data for all knee replacements done 
between the start of data collection on April 1, 2003, and 
Aug 28, 2012. Where possible, we linked these data to 
corresponding records in the HES database. Records could 
be linked to HES if they took place in, or were funded by, 
an NHS trust in England. HES provides additional 
information for every patient (including detailed 
comorbidity information and deprivation indices), and 
about every procedure (including length of stay and need 
for blood transfusion or critical care). Additional linked 
records contain details of readmissions, reoperations, and 
revisions not recorded in the NJR database. Data for all-
cause mortality are provided by the ONS; these data are 
linked periodically to the NJR database. The data used here 
were extracted from the NJR shortly after the latest NJR–
ONS linkage. Patients consent for their data to be collected 
from the NJR. The National Information Governance 
Board (now the Conﬁ dentiality Advisory Group) gave us 
permission to link the datasets (application number ECC 
1-02 (FT3)/2013). We consulted the National Research 
Ethics Service who conﬁ rmed that we did not need local 
research ethics committee approval.
Procedures  
We did analyses to compare the outcomes of TKR and 
UKR by six measures: rates of revision, revision/
reopera tion, and readmission; length of stay, 
complications of surgery, and mortality. To address the 
problem of confounding by indication, we have 
matched patients with propensity scoring techniques. 
We compared the reasons for revision (as reported by 
the operating surgeon) and the revision operation 
(exchange of modular components or secondary 
patellar resurfacing, conversion to primary TKR, 
complex revision) for the two procedures. Complex 
revisions were deﬁ ned as revisions to hinged 
components or components with stems or wedges, or 
two-stage procedures. We restricted our analyses to 
patients older than 18 years undergoing primary knee 
replacement for osteoarthritis. We excluded 
patellofemoral replacements, so-called complex 
primary knee replacements, and primary operations 
with augmentation and stems (implying a complex 
deformity). We showed signiﬁ cant diﬀ erences in 
baseline characteri stics between groups (table 1).
Statistical analysis  
We used propensity score matching to generate matched 
cohorts for comparison.16 First, we estimated the eﬀ ects 
of each confounder on treatment allocation using a 
logistic regression model. Using these estimates, we 
generated a score representing the probability of each 
knee receiving UKR; we matched three TKR patients to 
every one UKR patient on the basis of this propensity 
Survival for TKR (%; 95% CI) Survival for UKR (%; 95% CI) Hazard*/subhazard† ratio (95% CI) NNT (95% CI)
Revision
4 years 96·4% (96·2–96·5) 92·7% (92·3–93·1) 1·97 (1·84–2·12) 30·0 (26·1–34·7)
8 years 94·6% (94·2–94·9) 87·0% (86·2–87·9) 2·12 (1·99–2·26) 17·6 (15·6–19·9)
Revision/ reoperation
Overall 87·2% (86·7–87·8) 80·4% (79·4–81·4) 1·38 (1·31–1·44) 14·7 (13·2–16·6)
0–3 months .. .. 0·46 (0·38–0·56) ..
3 months–8 years .. .. 3·34 (2·75–4·07) ..
Mortality
30 days 99·76% (99·71–99·81) 99·94% (99·88–99·97) 0·23 (0·11–0·50) 543·6 (467·2–839·6)
90 days 99·53% (99·45–99·59) 99·78% (99·68–99·85) 0·47 (0·31–0·69) 399·0 (309·9–696·7)
1 year 99·22% (99·15–99·28) 99·47% (99·37–99·55) 0·69 (0·58–0·83) 420·2 (303·9–778·2)
4 years 95·66% (95·46–95·84) 96·71% (96·41–96·98) 0·75 (0·68–0·82) 93·5 (75·6–732·7)
8 years 88·52% (87·85–89·16) 89·10% (88·06–90·06) 0·85 (0·79–0·92) 62·1 (43·4–115·5)
Hazard ratios less than 1 favour unicompartmental knee replacement. The revision/reoperation hazard ratios are split because of time-varying hazard (see text); survival and NNT are 
provided at 8 years. NNT=number needed to treat (ie, number of patients switching treatment to avoid one adverse event). TKR=total knee replacement. UKR=unicompartmental 
knee replacement. *Hazard ratios are provided for mortality (Cox regression). †Subhazard ratios are provided for revision and revision/reoperation (competing risks regression).
Table 2: Propensity-score matched survival models by timepoints up to 8 years by outcome
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score. When calculating the propensity score, we 
included confounders consisting of age, sex, ethnic 
origin, Charlson comorbidity index, American Society 
of Anaesthesiologists (ASA) score, Index of Multiple 
Deprivation (in quintiles and by each subgroup), 
implant ﬁ xation, type of mechanical or chemical 
thromboprophylaxis, unit type (public, private, 
independent sector treatment centre), surgical caseload 
(the combined number of TKRs and UKRs done by the 
surgeon in charge in the year of surgery), and the grade 
of the primary surgeon (consultant or trainee). Body-
mass index (BMI) had a large proportion of missing 
data and, we therefore did not include it in the 
propensity score analysis. As a sensitivity analysis, we 
calculated estimates for complete case datasets, with 
and without BMI, and after completing the missing 
values using multiple imputation (appendix).
We used proportional hazards regression to examine 
survival outcomes (revision, revision/reoperation, and 
mortality). Because mortality can be regarded as a 
competing risk for revision surgery, we used competing 
risk regression when examining revision and revision/
reoperation;17 we used Cox regression for the mortality 
comparison. We examined continuous outcomes (length 
of stay) using linear regression and binary outcomes 
(complications  during the primary admission) using 
logistic regression, and examined readmission rate 
(within the ﬁ rst year) using a zero-inﬂ ated Poisson model.
For the survival models, we tested the proportional 
hazards assumption using Schoenfeld’s residuals. If the 
proportional hazards assumption was violated, we 
analysed survival hazards in sections, with breaks being 
placed at the points of divergence from proportionality. 
Results of these models are presented as overall survival 
percentages, hazard ratios, and numbers needed to treat 
(NNT, representing the number needing to switch from 
one procedure to the other to avoid one adverse event, 
calculated with Altman and colleagues’18 method).
Figure 1: Kaplan-Meier curve of revision (A) and revision/reoperation (B) to 8 years in matched patients
UKR=unicompartmental knee replacement. TKR=total knee replacement.
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We used Stata (version 12.1) for all statistical analyses, 
and used R (R Foundation for Statistical Computing, 
Vienna, Austria) to do the matching on the basis of 
propensity score.
Role of the funding source  
The sponsors of the study had no role in the design or 
conduct of the study. All authors had full access to the 
data and take responsibility for the contents of the 
study and the decision to proceed to publication. DWM 
is the guarantor.
Results
From a pool of 552 015 records from the NJR, and after 
exclusion of patellofemoral and complex primary knee 
replacements, a total of 341 749 records (315 767 TKRs and 
25 982 UKRs) could be linked to HES records. We recorded 
signiﬁ cant diﬀ erences in several baseline variables 
(table 1). On the basis of propensity score, 25 334 (98%) of 
25 982 UKRs could be matched to TKRs. Because we 
matched on a ratio of three TKRs to each UKR, the 
matched study group consisted of 101 330 knees, of which 
75 996 were TKRs. After matching, we achieved balance 
with respect to confounding factors (table 1).
After matching, implant survival at 8 years (with all-
cause revision as the endpoint) was greater for TKR than 
for UKR (table 2, ﬁ gure 1). Inclusion of all reoperations 
reduced overall survival values and attenuated the 
diﬀ erence between TKR and UKR. At 8 years, implant 
survival (with revision/reoperation as the endpoint) was 
greater for TKR than for UKR (subhazard ratio 1·38, 
95% CI 1·31–1·44; table 2). The survival hazard for 
reoperation varied with time. More reoperations were 
done for TKR than for UKR in the ﬁ rst 3 months before 
the TKR hazard became shallower and the hazards crossed 
at around 15 months (ﬁ gure 2). Therefore, a break was 
introduced at 3 months; in the ﬁ rst 3 months, the revision/
reoperation rate was signiﬁ cantly higher for TKR than for 
UKR; between 3 months and 8 years the risk of revision/
reoperation was signiﬁ cantly higher for UKR than for TKR 
(table 2).
Mortality was signiﬁ cantly higher for TKR at all 
timepoints (table 2). At 30 days, 90 of 76 074 patients 
(cumulative mortality rate 0·24%, 95% CI 0·19–0·29) had 
died in the TKR group compared with seven of 25 358 
(0·06%, 0·03–0·12) in the UKR group. Hazard ratios 
were 0·23 (0·11–0·50) at 30 days and 0·47 (0·31–0·69) at 
90 days. Although the hazard ratio fell with time, the 
absolute diﬀ erence in death rates increased to 1·1% 
(0·7–1·4%) at 4 years, before decreasing to 0·7% 
(−0·5 to 1·9) at 8 years (ﬁ gure 2).
Mean length of stay was 1·38 days shorter for UKR than 
for TKR (mean 5·52 [SD 3·97] for TKR; 4·14 [2·24] for 
UKR; 95% CI 1·33–1·43, p<0·0001) and readmission 
within the ﬁ rst year was signiﬁ cantly less likely in UKR 
than in TKR (incidence rate ratio 0·65, 0·58–0·72). 
Intraoperative complications, blood transfusion, 
thromboembolism, stroke, and myocardial infarction were 
signiﬁ cantly less likely for UKR than for TKR (table 3).
Reasons for revision diﬀ ered between TKR and UKR 
(table 4). Although aseptic loosening was the commonest 
reason for revision after either operation, signiﬁ cantly 
more TKRs than UKRs were revised for infection and 
stiﬀ ness. Progression of arthritis and bearing dislocation 
are modes of failure that were almost exclusive to UKR, 
and as a result, the odds ratio for revision for either 
reason greatly favoured TKR. Unexplained pain, aseptic 
loosening, malalignment, wear, periprosthetic fracture, 
and other unspeciﬁ ed reasons for revision were 
signiﬁ cantly more common in UKR than in TKR. The 
proportion of patients being revised for instability or 
implant fracture was much the same for the two 
operations (table 4).
Although most revisions in TKR required augments or 
constrained implants, most of those recorded for UKR in 
the NJR were conversions to a primary TKR. These 
conversion-type operations accounted for the diﬀ erence 
Crude comparisons Propensity matched comparisons
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Intraoperative complications 0·70 (0·57–0·87) 0·001 0·73 (0·58–0·91) 0·006
Critical care admission 0·72 (0·60–0·86) <0·001 0·84 (0·69–1·02) 0·075
Blood transfusion 0·18 (0·12–0·26) <0·001 0·25 (0·17–0·37) <0·0001
Thromboembolism 0·42 (0·34–0·52) <0·001 0·49 (0·39–0·62) <0·0001
Stroke 0·28 (0·13–0·63) 0·002 0·37 (0·16–0·86) 0·021
Myocardial infarction 0·32 (0·20–0·52) <0·001 0·53 (0·31–0·90) 0·018
Odds ratios less than 1 favour unicompartmental knee replacement.
Table 3: Crude and matched logistic models for complications
TKR UKR Hazard ratio (95% CI) p value
Rank N (%) Rank N (%)
Loosening/lysis 1= 351 (25·1) 1 385 (30·1) 3·17 (2·75–3·67) <0·0001
Infection 1= 351 (25·1) 7 61 (4·8) 0·50 (0·38–0·66) <0·0001
Pain 3 152 (10·9) 2 264 (20·6) 5·08 (4·16–6·21) <0·0001
Instability 4 141 (10·1) 8 58 (4·5) 1·20 (0·88–1·62) 0·254
Malalignment 5 107 (7·7) 6 76 (5·9) 2·04 (1·52–2·75) <0·0001
Stiﬀ ness 6 99 (7·1) 11 12 (0·9) 0·36 (0·20–0·66) 0·001
Other reasons 7 88 (6·3) 4 135 (10·6) 4·40 (3·36–5·76) <0·0001
Dislocation/dissociation 8 30 (2·2) 5 92 (7·2) 10·01 (6·52–15·38) <0·0001
Wear 9 30 (2·2) 9 27 (2·1) 2·49 (1·48–4·20) 0·001
Progression of disease 10 27 (1·9) 3 144 (11·3) 15·09 (10·00–22·78) <0·0001
Periprosthetic fracture 11 15 (1·1) 10 22 (1·7) 4·24 (2·19–8·18) <0·0001
Implant fracture 12 5 (0·4) 12 3 (0·2) 1·68 (0·40–7·05) 0·478
Total ·· 1396 ·· 1279 ·· ··
Percentages are the percentage of all revisions that are done for the reason given. Hazard ratios represent the overall 
risk of being revised for each reason at 8 years. Hazard ratios less than 1 favour unicompartmental knee replacement. 
TKR=total knee replacement. UKR=unicompartmental knee replacement.
Table 4: Reasons for revision in unicompartmental knee replacement (UKR) and total knee replacement 
(TKR; matched analysis, revisions recorded in NJR only)
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in the revision rate between UKR and TKR. The 
probability of part revisions (including secondary patellar 
resurfacing in TKR, and bearing exchange in UKR) did 
not diﬀ er between TKR and UKR, nor did they for 
complex revisions (table 5).
Discussion
This study shows a signiﬁ cantly higher risk of revision/
reoperation in patients undergoing UKR than for matched 
patients undergoing TKR. However, patients undergoing 
TKR are at increased risk of medical complications; they 
are twice as likely to have a venous thromboembolism, 
myocardial infarction, or deep infection, three times as 
likely to have a stroke, and four times as likely to need 
blood transfusions. As a result, these patients are four 
times more likely to die in the ﬁ rst 30 days after surgery 
and about 15% more likely to die during the ﬁ rst 8 years. 
Inpatient stays are longer, and readmissions are more 
likely after TKR than after UKR. Revisions of TKRs are 
more commonly due to stiﬀ ness or infection, whereas 
revisions of UKR are more usually done for unexplained 
pain, arthritis progression, or other unspeciﬁ ed reasons. 
Most revisions of UKR are conversions to a primary TKR, 
whereas most revisions of TKR are more complex 
procedures requiring larger components and increased 
levels of constraint—constrained implants introduce more 
tibiofemoral conformity to address the instability caused 
by the loss of the normal soft-tissue and bony constraints 
during revision knee surgery. Conversion-type operations 
accounted for all the diﬀ erence in the revision rate between 
UKR and TKR.
In patients with disease suitable for TKR or UKR, the 
decision of which procedure to oﬀ er should take into 
account the advantages and disadvantages of each, both in 
terms of functional results and of adverse outcomes. 
Although previous studies have examined functional 
outcomes, we have focused on adverse outcomes.19,20 In 
the short term, UKR has proved to have clear advantages, 
with reduced hospital stays, complications, readmissions, 
and mortality; however, it does have the disadvantage of 
an increased revision and reoperation rate. The diﬀ erence 
in revisions largely consists of conversion-type operations, 
which are similar to a primary TKR. When oﬀ ered a 
choice of elective surgical procedures, patients are likely to 
rate mortality and major complications (such as 
myocardial infarction and stroke) as the worst possible 
outcomes. As such, these outcomes should be as, or more, 
important factors in the decision about which procedure 
to oﬀ er compared with the risk of reoperation/revision. 
Although revision is a deeply undesirable result after joint 
replacement, mortality after elective surgery is devastating.
Revision, reoperation, and death are uncommon 
outcomes of either procedure. At 4 years, the NNT to 
avoid a revision is 30 cases and to avoid a death is 93, 
whereas 8 years the NNT to avoid a revision is 18 cases 
and to avoid a death is 62. However, because knee 
replacement is very common, even small percentage 
diﬀ erences aﬀ ect large numbers of patients. Although 
estimates of the proportion of patients eligible for UKR 
vary (and have been estimated at up to 47%10), a 
conservative estimate from a previous study11 suggested 
that, at present, 21% of patients undergoing TKR meet 
the criteria for UKR. At 4 years, if 21% of the patients in 
the NHS currently undergoing TKR underwent UKR 
instead, a potential annual saving of 169 deaths, at the 
cost of 405 additional revisions, would result. However, 
as the revision rate of UKR tends to decrease with 
increasing surgeon volume, if these surgeons perform 
more UKRs per year, there might be fewer additional 
revisions.21
The diﬀ erence in revision rates between UKR and TKR 
has been well described (panel).1,3,4 In this study, this 
diﬀ erence is smaller than that shown in registry reports 
(which are unadjusted for patient characteristics)3,4,11 and 
observational studies (which have varying degrees of 
adjustment).23,24 This diﬀ erence suggests that patient 
selection for UKR or TKR exerts a powerful eﬀ ect on 
ultimate revision rate. Inclusion of reoperations, which 
registries do not class as revisions, eﬀ aces this eﬀ ect 
further. Reasons for the residual diﬀ erence are 
multifactorial and include the presence of additional 
failure mechanisms in UKR (mainly progression of 
disease), more subtle patient factors (such as the degree 
of cartilage damage before surgery),30 and threshold for 
revision. UKR is easier to revise than TKR, and revision 
usually results in a primary TKR. As a result, UKR is ﬁ ve 
times more likely to be revised than a TKR with the same 
patient-reported outcome.19
TKR UKR Hazard ratio
(95% CI)
p value
N % of 
revisions
% of all 
cases
N % of 
revisions
% of all 
cases
Bearing/patella 259 19% <1% 81 6% <1% 0·90 (0·70–1·16) 0·430
Revision to primary total knee replacement 247 18% <1% 854 67% 3% 10·07 (8·74–11·62) <0·0001
Complex revision 890 64% 1% 344 27% 1% 1·12 (0·99–1·27) 0·068
Total 1396 ·· ·· 1279 ·· ·· ·· ··
Hazard ratios less than 1 favour unicompartmental knee replacement. TKR=total knee replacement. UKR=unicompartmental knee replacement.
Table 5: Type of revision operation (matched analysis, revisions recorded in NJR)
Articles
www.thelancet.com   Vol 384   October 18, 2014 1443
Diﬀ erences in mortality between the two procedures 
have been previously reported;28 however, as far as we are 
aware this study is the ﬁ rst to conﬁ rm this ﬁ nding in 
matched patients and the ﬁ rst to show an eﬀ ect in the 
medium term. The reasons for the diﬀ erences recorded 
have been discussed in the accompanying paper,31 but the 
primary reason is likely to be that UKR surgery is less 
invasive, both for soft tissue and bone, than is TKR.12,32 
Similar factors explain the ﬁ ndings for perioperative 
morbidity. In addition to the short-term eﬀ ect, this study 
shows that, although the eﬀ ect of surgery on mortality is 
attenuated over time, an eﬀ ect is seen into the medium 
term. Causality is more diﬃ  cult to prove at longer follow-
up times, but might be related to long-term consequences 
of complications of surgery, such as myocardial 
infarction, stroke, venous thromboembolism, or 
prosthetic joint infection, which we have shown to be 
more common in TKR than in UKR.
The strengths of this study include the use of an 
unselected registry sample, reducing the likelihood of 
sampling bias. The use of linked NJR/HES datasets 
allows adjustment for a very large set of potential 
confounders. The use of propensity score matching 
allows comparison of comparable cohorts and addresses 
the risk of confounding by indication.16 This study is the 
most comprehensively matched study of these two 
treatments so far.
Weaknesses relate to the observational nature of the 
study. To address sources of bias, we matched the patients, 
which raises the possibility that some of the ﬁ ndings, 
particularly diﬀ erences in long-term mortality, could 
result from inadequate matching. If matching were 
inadequate, then the diﬀ erence in mortality would be 
expected to progressively increase over time. However, 
although the survival curves for mortality diverge 
progressively for 4 years, they become parallel or converge 
slightly in the second half of the study, which is what 
would be expected because medical complications of 
surgery would only aﬀ ect mortality for a limited time.
The matching process might also restrict the external 
validity of the study by excluding unmatchable patients. 
However, the crude diﬀ erences between the groups were 
not large, and 25 329 (97·5%) of 25 982 UKRs could be 
matched to a TKR. This ﬁ nding could be attributable to 
the fact that patients who are eligible for UKR could be 
oﬀ ered TKR or UKR, dependent on their surgeon’s 
views, and suggests that the ﬁ ndings shown here might 
be generalisable to the wider population of patients who 
are appropriate for UKR.
Propensity score matching has been used for more 
than 30 years and has gained popularity in diverse 
specialties of medicine, social sciences, and economics.33,34 
In that time, the understanding of the strengths and 
limitations of propensity score matching has increased.35 
Although the aim of propensity score matching is to 
recreate the conditions of a randomised trial in an 
observational study, this can only be the case if all causes 
of confounding by indication are eliminated by the 
matching process (the principle of strong ignorability33). 
In reality, all observational studies will have a degree of 
unmeasured confounding and the results of propensity 
score matched studies such as this must be interpreted 
with this in mind.35 In this study, patients were matched 
for 20 variables, and the eﬀ ect of a 21st, BMI, was 
examined after matching and shown not to aﬀ ect 
outcome (appendix). Potential sources of unmeasured 
Panel: Research in context
Systematic review
We searched Medline, Embase, and the Cochrane Library on July 31, 2013, to retrieve all 
studies comparing unicompartmental knee replacement (UKR) and total knee replacement 
(TKR) in terms of revision rate, mortality, or complications. Clinical trials and observational 
studies were included in the review. Additionally, the latest annual reports of six major NJRs 
(England and Wales, Australia, New Zealand, Sweden, Norway, and Denmark) and one large 
regional joint registry (Emilia-Romagna, Italy) were retrieved and interrogated. The search 
identiﬁ ed two randomised trials,20,22 two retrospective cohort studies,12,23 and three case-
control studies.24–26 One retrospective study (examining patients with UKR in one knee and 
TKR in the other) was excluded from the review because it studied a design of UKR that has 
subsequently been withdrawn as a result of design factors leading to a high revision rate.27 
Only two randomised control trials comparing the two procedures exist. The ﬁ rst, a study of 
102 patients at 15 years, reported implant survival at 89·8% (95% CI 74·3–100) for UKR and 
78·7% (56·2–100) for TKR, with better functional outcomes with UKR than with TKR.20 
However, substantial attrition was noted, with 45 (44%) of 102 knees in patients who died 
before 15 years. The second, of 104 knees at very early follow-up, reported better survival 
with TKR than with UKR at the cost of a higher rate of deep vein thrombosis and a greater fall 
in haemogolobin concentration with TKR.22 All major joint registries show a higher revision 
rate for UKR than for TKR. Unmatched data from the NJR annual report shows hazard ratios 
between 2·9 and 3·7;1 similar data from Australia show similar hazard ratios of 2·59 (95% CI 
2·50–2·69) and from New Zealand of 2·72 (2·47–2·99).3,4 Mortality in UKR and TKR has been 
little studied. The NJR 7th annual report shows hazard ratios of 0·36 (95% CI 0·22–0·58) at 
90 days and 0·64 (0·58–0·72) at 5 years, adjusted for age, sex, and American Society of 
Anaesthesiologists’ grade.28 A large observational study of 2840 TKRs and UKRs adjusted for 
age, sex, body-mass index, and comorbidities showed signiﬁ cantly increased rates of 
manipulation under anaesthesia (odds ratio 13, p<0·001), admission to critical care (7·4, 
p=0·049), and postoperative transfusion (8·5, p=0·036), and for complications overall (2·8, 
p<0·001).12 In a smaller study, Lombardi and colleagues26 reported a shorter length of stay 
(1·4 days for UKR vs 2·2 days for TKR, p<0·001); similar differences are reported in two other 
small studies.25,29 In Lyons and colleagues’23 retrospective cohort study, reduced survival for 
UKR was reported with an institutional database (5606 TKRs and 279 UKRs, 10 year survival 
95% for TKR, 90% for UKR), and in the small case-control study of Amin and colleagues.24
Interpretation
Our study is the most comprehensive comparison of UKR and TKR that has been done so 
far. The NJR is the largest joint replacement database in the world, and our study is the 
ﬁ rst to address the problem of confounding by indication with propensity score 
techniques. Most previous comparisons of the two techniques have compared survival 
alone, and this is the ﬁ rst study to compare TKR and UKR with such a wide selection of 
endpoints. This study has supported ﬁ nding of a higher revision and revision/reoperation 
rate reported by earlier joint registery studies, but has also shown important advantages 
of UKR in terms of speed of recovery, rate of readmission, ease of revision, morbidity, and 
mortality. Patient-reported outcomes have not been examined in this study, but previous 
work has suggested that they could be better in TKR than in UKR. Future studies should 
examine patient-reported outcomes.
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confounding include the radiological stage of disease 
(patients with only partial loss of cartilage thickness are 
more prone to revision than those with full-thickness 
cartilage defects30); diﬀ erences in complexity of operation 
(although cases with augmentation and those labelled as 
complex primaries are excluded, there might be more 
subtle diﬀ erences between procedures); more detailed 
patient-level comorbidity data (although reliability of 
HES comorbidity data are well established36,37), and level 
of preoperative activity. A randomised trial would be 
required to address these limitations; such a trial is in 
progress.38 However, the primary outcomes of this trial 
are patient-reported outcome measures; the size of a 
randomised controlled trial that would be required to 
produce meaningful information about rarer outcomes 
such as mortality is prohibitive. Such questions are best 
answered with observational study designs.
The choice of which procedure to oﬀ er will depend on 
the individual patient. Decisions about treatment should 
be made on the basis of all outcome measures, not merely 
the revision rate of each procedure. This study should 
provide important evidence for making such decisions.
Contributors
ADL conceived the study, did the statistical analyses, and drafted the 
manuscript. AJ contributed substantially to the statistical design and 
analysis and made major contributions to the writing of the paper. 
HP made substantial contributions to the conception of the work and 
the drafting of the manuscript. DWM contributed substantially to the 
conception and design of the study and made signiﬁ cant revisions to the 
manuscript. All authors approved the submitted version and agree to be 
accountable for all aspects of the work.
Declaration of interests
ADL declares that he has no competing interests. HP has been a paid 
speaker for Biomet, who are manufacturers of orthopaedic implants 
including unicompartmental and total knee replacements. DWM 
receives royalties related to the Oxford UKR and is paid consultancy fees 
by Biomet. AJ has received honoraria from Roche, held advisory board 
positions (which involved receipt of fees) for Anthera, and received 
consortium research grants from Servier; none of these entities were 
related to this study. The Nuﬃ  eld Department at Oxford receives 
research funding from Biomet, Stryker, and Zimmer, all of whom are 
manufacturers of orthopaedic implants. None of these companies were 
involved in the funding or conduct of this study.
Acknowledgments
We thank the patients and staﬀ  of all the hospitals in England and Wales 
who have contributed data to the National Joint Registry; and the 
Healthcare Quality Improvement Partnership (HQIP), the NJR Steering 
Committee, and staﬀ  at the NJR Centre for facilitating this work. The 
authors have conformed to the NJR’s standard protocol for data access and 
publication. The views expressed represent those of the authors and do not 
necessarily reﬂ ect those of the National Joint Registry Steering Committee 
or the Healthcare Quality Improvement Partnership (HQIP) who do not 
vouch for how the information is presented. HES data copyright © 2013, 
Re-used with the permission of the Health & Social Care Information 
Centre. All rights reserved. During the conduct of this study, ADL has 
been supported by research fellowships from the Royal College of 
Surgeons of England and Arthritis Research UK (grant no. 20499).
References
1 National Joint Registry for England, Wales and Northern Ireland. 
10th annual report, 2013. http://www.njrcentre.org.uk/njrcentre/
LinkClick.aspx?ﬁ leticket=jEAdoNJbxvk%3d&tabid=330&portalid=0
&mid=1191 (accessed June 24, 2014).
2 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary 
and revision hip and knee arthroplasty in the United States from 
2005 to 2030. J Bone Joint Surg Am 2007; 89: 780–85.
Articles
www.thelancet.com   Vol 384   October 18, 2014 1445
25 Manzotti A, Confalonieri N, Pullen C. Unicompartmental versus 
computer-assisted total knee replacement for medial compartment 
knee arthritis: a matched paired study. Int Orthop 2007; 31: 315–19.
26 Lombardi AV Jr, Berend KR, Walter CA, Aziz-Jacobo J, Cheney NA. 
Is recovery faster for mobile-bearing unicompartmental than total 
knee arthroplasty? Clin Orthop Relat Res 2009; 467: 1450–57.
27 Costa CR, Johnson AJ, Mont MA, Bonutti PM. Unicompartmental 
and total knee arthroplasty in the same patient. J Knee Surg 2011; 
24: 273–78.
28 National Joint Registry for England and Wales. The 7th Annual 
Report, 2010. http://www.njrcentre.org.uk/NjrCentre/Portals/0/
NJR%207th%20Annual%20Report%202010.pdf (accessed 
June 24, 2014).
29 Yang KY, Wang MC, Yeo SJ, Lo NN. Minimally invasive unicondylar 
versus total condylar knee arthroplasty--early results of a 
matched-pair comparison. Singapore Med J 2003; 44: 559–62.
30 Niinimäki TT, Murray DW, Partanen J, Pajala A, Leppilahti JI. 
Unicompartmental knee arthroplasties implanted for osteoarthritis 
with partial loss of joint space have high re-operation rates. 
Knee 2011; 18: 432–35.
31 Hunt LP, Ben-Shlomo Y, Clark EM, et al. 45-day mortality after 
467 779 knee replacements for osteoarthritis from the National Joint 
Registry for England and Wales: an observational study. Lancet 2014; 
published online July 8. http://dx.doi.org/10.1016/S0140-
6736(14)60540-7.
32 Morris MJ, Molli RG, Berend KR, Lombardi AV Jr. Mortality 
and perioperative complications after unicompartmental knee 
arthroplasty. Knee 2013; 20: 218–20.
33 Pearl J. Understanding Propensity Scores. Causality. 2nd ed. 
New York: Cambridge University Press; 2009: 348–52.
34 Rosenbaum PR, Rubin DB. The central role of the propensity 
score in observational studies for causal eﬀ ects. Biometrika 1983; 
70: 41–55.
35 Freemantle N, Marston L, Walters K, Wood J, Reynolds MR, 
Petersen I. Making inferences on treatment eﬀ ects from real world 
data: propensity scores, confounding by indication, and other perils 
for the unwary in observational research. BMJ 2013; 347: f6409.
36 Hunt LP, Ben-Shlomo Y, Clark EM, et al, and the National Joint 
Registry for England, Wales and Northern Ireland. 90-day mortality 
after 409,096 total hip replacements for osteoarthritis, from the 
National Joint Registry for England and Wales: a retrospective 
analysis. Lancet 2013; 382: 1097–104.
37 Aylin P, Alexandrescu R, Jen MH, Mayer EK, Bottle A. Day of week 
of procedure and 30 day mortality for elective surgery: retrospective 
analysis of hospital episode statistics. BMJ 2013; 346: f2424.
38 Beard D, Price A, Cook J, et al. Total or partial knee arthroplasty 
trial-TOPKAT: study protocol for a randomised controlled trial. 
Trials 2013; 14: 292.
